CTKB Stock-Based Compensation
Cytek Biosciences Inc · Stock-Based Compensation
CTKB Stock-Based Compensation
Latest reported$21.37Mperiod ending
CTKB TTM Stock-Based Comp ($611.00K → $21.37M)
TTM stock-based compensation
High-resolution chart · PNG
CTKB stock-based compensation history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Stock-Based Compensation (USD) |
|---|---|
| 21,365,000 | |
| 22,816,000 | |
| 24,585,000 | |
| 26,061,000 | |
| 27,476,000 | |
| 27,838,000 | |
| 26,848,000 | |
| 25,514,000 | |
| 24,219,000 | |
| 22,989,000 | |
| 22,048,000 | |
| 20,844,000 | |
| 19,445,000 | |
| 13,523,000 | |
| 12,661,000 | |
| 11,204,000 | |
| 6,845,000 | |
| 7,512,000 | |
| 4,131,000 | |
| 1,394,000 | |
| 1,520,000 | |
| 962,000 | |
| 611,000 |